Leeward Financial Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Leeward Financial Partners’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$888K	Hold	41,400	–	–	0.23%	61
2026 Q1	$575K	Hold	41,400	–	–	0.17%	64
2025 Q4	$672K	Sell	41,400 -10,250	-20%	-$167K	0.19%	58
2025 Q3	$773K	Hold	51,650	–	–	0.22%	58
2025 Q2	$602K	Hold	51,650	–	–	0.19%	61
2025 Q1	$384K	Hold	51,650	–	–	0.14%	64
2024 Q4	$310K	Hold	51,650	–	–	0.11%	72
2024 Q3	$264K	Hold	51,650	–	–	0.1%	76
2024 Q2	$187K	Hold	51,650	–	–	0.08%	84
2024 Q1	$166K	Sell	51,650 -2,447	-5%	-$9.47K	0.07%	92
2023 Q4	$265K	Hold	54,097	–	–	0.13%	74
2023 Q3	$295K	Hold	54,097	–	–	0.16%	64
2023 Q2	$363K	Hold	54,097	–	–	0.21%	64
2023 Q1	$478K	Hold	54,097	–	–	0.29%	56
2022 Q4	$413K	Sell	54,097 -13,000	-19%	-$101K	0.29%	57
2022 Q3	$478K	Hold	67,097	–	–	0.34%	54
2022 Q2	$543K	Sell	67,097 -1,407	-2%	-$12.4K	0.37%	53
2022 Q1	$951K	Sell	68,504 -2,472	-3%	-$38.9K	0.59%	47
2021 Q4	$1.99M	Buy	+70,976	New	+$2.18M	1.25%	31

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Leeward Financial Partners's ADPT Position: Q2 2026 in Review

Leeward Financial Partners held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 41,400 shares worth $888K. The position accounts for 0.23% of the portfolio, ranked #61.

Leeward Financial Partners first reported a position in ADPT in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.99M in Q4 2021. 298 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

Leeward Financial Partners held 41,400 shares of Adaptive Biotechnologies worth $888K as of Q2 2026.
Leeward Financial Partners left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up 0.23% of Leeward Financial Partners's portfolio in Q2 2026, its #61 holding.
Leeward Financial Partners first reported a position in Adaptive Biotechnologies in Q4 2021 and has held it in 19 quarters since.
Leeward Financial Partners's Adaptive Biotechnologies position peaked at $1.99M in Q4 2021.
298 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Leeward Financial Partners's 13F filing for Q2 2026, filed 6 Aug 2026.